Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often ...

Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...

VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), ...

ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 ...

A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...

NEW YORK (MedscapeWire) May 16 - Microvascular disease may predict subsequent development of type 2 diabetes mellitus even in patients thought to be at low risk, according to results of a study ...

Treatments for high blood pressure do not totally reverse its damaging effects on the vascular rhythms that help circulation of the blood say researchers. The World Health Organisation says ...

LOS ANGELES (KABC) -- Imagine a pain in your face that is so intense you can't talk, eat or move - it's called trigeminal neuralgia, and up to 15,000 people a year are diagnosed with it. When ...

Heart disease is the number-one killer of women, with over 60 million women (44%) in the U.S. living with some form of heart disease. There is one woman dying from heart disease every minute. The ...

Endotronix co-founder and former CEO joins VahatiCor as the company advances the A-FLUX Reducer System and the SERRA-I early feasibility study VahatiCor, Inc., a medtech company developing interventio ...